Refereed Articles.
1. Cook DR, Brandom BW, Shiu G, Wolfson B:
The inspired median effective dose, brain concentration of anesthesia,
and cardiovascular index for halothane in young rats. Anesth Analg
60:182-185, 1981.
2. Cook DR, Brandom BW: Enflurane, halothane,
and isoflurane inhibit removal of 5-hydroxytryptamine from pulmonary
circulation. Anesth Analg 61:671-675, 1982.
3. Brandom BW, Brandom RB, Cook DR: Uptake
and distribution of halothane in infants and adults in vivo measurements
and computer simulations. Anesth Analg 62:404-410, 1983.
4. Brandom BW, Rudd GD, Cook DR: Clinical
pharmacology of atracurium in pediatric patients. Brit J Anaesth
55:117S-121S, 1983.
5. Brandom BW, Woelfel SK, Cook DR: Clinical
pharmacology of atracurium in infants. Anesth Analg 63:309-312,
1984.
6. Alifimoff JK, Kaul S, Brandom BW, Cook
DR: Enflurane, halothane and isoflurane do not inhibit angiotensin
converting enzyme activity. Can Anesth Soc J 32:351-357, 1985.
7. Stiller RL, Brandom BW, Cook DR: Determination
of atracurium in plasma by high-performance liquid chromatography.
Anesth Analg 64:58-62, 1985.
8. Brandom BW, Cook DR, Woelfel SK, Rudd GD:
Atracurium infusion requirements in children during halothane,
isoflurane, and narcotic anesthesia. Anesth Analg 64:471-476,
1985.
9. Pollock BG, Perel JM, Brandom BW, Antelman
S, Kupfer DJ: Understanding the response lag to tricyclics I.
Application of pulse-loading regimens with intravenous clomipramine.
Psychopharmacology 22:214-219, 1986.
10. Brandom BW, Stiller RL, Cook DR, Woelfel
SK, Chakravorti S, Lai A: Pharmacokinetics of atracurium in anesthetized
infants and children. Br J Anesth 58:1210-1213, 1986.
11. Sarner JB, Brandom BW, Cook DR, Dong ML,
Horn MC, Woelfel SK, Davis PJ, Rudd GD, Foster VJ, McNulty BF:
Clinical pharmacology of doxacurium chloride (BW A938U) in children.
Anesth Analg 67:303-306, 1988.
12. Davis PJ, Stiller RL, Cook DR, Brandom BW,
Davin-Robinson KA: Pharmacokinetics of sufentanil in adolescent
patients with chronic renal failure. Anesth Analg 67:268-271,
1988.
13. Weber S, Brandom BW, Powers DM, Sarner
JB, Woelfel SK, Cook DR, Foster VJ, McNulty BF, Weakly JN: Mivacurium
chloride (BW B1090U) induced neuromuscular blockade during nitrous
oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult
surgical patients. Anesth Analg 67:495-499, 1988.
14. Sarner JB, Brandom BW, Woelfel SK, Dong
ML, Horn MC, Cook DR, McNulty BF, Foster VJ: Clinical pharmacology
of mivacurium chloride (BW B1090U) in children during nitrous
oxide-halothane and nitrous oxide-narcotic anesthesia. Anesth
Analg 68:116-121, 1989.
15. Davis PJ, Stiller RL, Cook DR, Brandom BW,
Davis JE, Scierka AM: Effects of cholestatic hepatic disease and
chronic renal failure on alfentanil pharmacokinetics in children.
Anesth Analg 68:579-583, 1989.
16. Cook DR, Stiller RL, Weakly JN, Chakravorti S,
Brandom BW, Welch RM: In vitro metabolism of mivacurium
chloride (BW B1090U) and succinylcholine. Anesth Analg 68:452-456,
1989.
17. Brandom BW, Woelfel SK, Cook DR, Weber
S, Powers DM, Sarner JB, Weakly JN: Comparison of mivacurium chloride
(BW B1090U) and suxamethonium chloride administered by bolus and
infusion during nitrous oxide-oxygen-opioid anesthesia. Br J Anaesth
62:488-493, 1989.
18. Law SC, Ramzan IM, Brandom BW, Cook DR:
Intravenous ranitidine antagonizes intense atracurium-induced
neuromuscular blockade in rats. Anesth Analg 69:611-613, 1989.
19. Tullock WC, Diana P, Cook DR, Wilks DH, Brandom
BW, Stiller RL, Beach CA: Neuromuscular and cardiovascular
effects of high-dose vecuronium. Anesth Analg 70:86-90, 1990.
20. Boston JR, Davis PJ, Brandom BW, Roeber
CM: Rate of change of somatosensory evoked potentials in newborn
piglets. Anesth Analg 70:275-283, 1990.
21. Brandom BW, Sarner JB, Woelfel SK, Dong
ML, Horn MC, Borland LM, Cook DR, Foster VJ, McNulty BF, Weakly
JN: Mivacurium chloride (BW B1090U) infusion requirements in pediatric
surgical patients during nitrous oxide-halothane and nitrous oxide-narcotic
anesthesia. Anesth Analg 71:16-22, 1990.
22. Sarner JB, Brandom BW, Dong ML, Pickle
D, Cook DR, Weinberger MJ: Clinical pharmacology of pipecuronium
in infants and children during halothane anesthesia. Anesth Analg
71:362-366, 1990.
23. Woelfel SK, Dong ML, Brandom BW, Sarner
JB, Cook DR: Vecuronium infusion requirements in children during
halothane-narcotic-nitrous oxide, isoflurane-narcotic-nitrous
oxide, and narcotic-nitrous oxide anesthesia. Anesth Analg 73:33-38,
1991.
24. Kosko JR, Brandom BW, Chan KH: Masseter
spasm and malignant hyperthermia: A retrospective review of a
hospital-based pediatric otolaryngology practice.
Int J Pediatr Otorhinolaryngol 23:45-50, 1992.
25. Blinn A, Woelfel SK, Cook DR, Brandom BW,
Cohen IT: Pancuronium dose-response revisited. Paediatric Anaesthesia
2:153-155, 1992.
26. Powers DM, Brandom BW, Cook DR, Byers
R, Sarner JB, Simpson K, Weber S, Woelfel SK, Foster VJ: Mivacurium
infusion during nitrous oxide-isoflurane anesthesia: a comparison
with nitrous oxide-opioid anesthesia. Journal of Clinical Anesthesia
4:123-126, 1992.
27. D'Angelo R, Cohen IT, Brandom BW: Continuous
epidural infusion of bupivacaine and fentanyl for erythromelalgia
in an adolescent. (Case Report) Anesth Analg 74:142-144, 1992.
28. Woelfel SK, Brandom BW, Cook DR, Sarner
JB: Effects of bolus administration of ORG-9426 in children during
nitrous oxide-halothane anesthesia. Anesthesiology 76:939-942,
1992.
29. Brandom BW, Meretoja OA, Taivainen T,
Wirtavuori K: Accelerated onset and delayed recovery of neuromuscular
block induced by mivacurium preceded by pancuronium in children.
Anesth Analg 76:998-1003, 1993.
30. Meretoja OA, Brandom BW, Taivainen T,
Jalkanen L: Synergism between atracurium and vecuronium in children.
Br J Anaesth 71:440-442, 1993.
31. Woelfel SK, Brandom BW, McGowan FX, Cook
DR: Clinical pharmacology of mivacurium in pediatric patients
less than two years old during nitrous oxide-halothane anesthesia.
Anesth Analg 77:713-720, 1993.
32. Woelfel SK, Brandom BW, McGowan Jr. FX,
Gronert BJ, Cook DR: Neuromuscular effects of a bolus of 600 µg.kg-1
of rocuronium in infants during nitrous oxide-halothane anaesthesia.
Paediatric Anaesthesia 4:173-177, 1994.
33. Meretoja OA, Taivainen T, Brandom BW,
Wirtavuori K: Frequency of train-of-four stimulation influences
neuromuscular response. Br J Anaesth 72:686-687, 1994.
34. Jalkanen L, Meretoja OA, Taivainen T, Brandom
BW, Dayal B: Synergism between atracurium and mivacurium compared
with that between vecuronium and mivacurium. Anesth Analg 79:998-1002,
1994.
35. Theroux MC , Brandom BW, Zagnoev M, Kettrick
RG, Miller F, Ponce C: Dose response of succinylcholine at the
adductor pollicis of children with cerebral palsy during propofol
and nitrous oxide anesthesia. Anesth Analg 79:761-765, 1994.
36. Brandom BW, Taiwo OO, Woelfel SK, Schon
H, Gronert BJ, Cook DR: Spontaneous Versus Edrophonium-Induced
Recovery from Paralysis with Mivacurium. Anesth Analg 82: 999-1002,
1996.
37. Brandom BW, Yellon RF, Lloyd ME, Gronert
BJ, Theroux M, Simhi E, Chakravorti S , Venkataraman
S, Dohar JE, Shapiro AM, Rimmel FL, Reilly J. Recovery from Doxacurium
Infusion Administered to Produce Immobility for More Than Four
Days in Pediatric Patients in the Intensive Care Unit. Anesthesia
Analgesia, in press, 1997.
38. Simhi E, Brandom BW, Lloyd ME, Woelfel
SK: Administration of atropine and onset of neuromuscular block
produced by atracurium in infants. Pediatric Anaesthesia, in press,
1997.
Reviews, Invited Published Papers, Proceedings
of Conference and Symposia, Monographs, Books and Book Chapters.
Reviews:
1. Brandom BW, Cook DR: The clinical use of
muscle relaxants in infants and children. In: Current Reviews
in Clinical Anesthesia, Volume 4, Miami, Florida, 1984.
2. Brandom BW, Cook DR: Muscle relaxants in
children. In: Seminars in Anesthesia, Vol IV, edited by
Katz R, Grunne and Stratton, Inc., New York, 4:41-51, 1985.
3. Brandom BW: Neuromuscular blocking drugs
in infants and children. Current Opinion in Anesthesiology,
1:24-30, 1988.
4. Brandom BW: New developments in pediatric
anesthesia: Neuromuscular blocking drugs. Anesthesiology Clinics
of North America, edited by Lerman J, C.V. Mosby Co., St.
Louis, MO, 9:781-800, December 1991.
5. Law SC, Brandom BW: Monitoring neuromuscular
function in the pediatric patient. In: International Anesthesiology
Clinics, Anesthesia Equipment for Infants and Children, edited
by Pullerits J and Holzman R, Little Brown and Co., Boston, MA,
30(3):147-162, 1992.
6. Brandom BW, Davis PJ: Changes in drug requirements
during growth. Current Opinion in Anaesthesiology 5:374-379,
1992.
7. Brandom BW: New neuromuscular blocking
drugs in anesthetized pediatric patients. Current Reviews in
Clinical Anesthesia 12 (Lesson 26):8/13/92.
8. Woelfel SK, Brandom BW: Neuromuscular blocking
drugs in pediatric anesthesia. Seminars in Anesthesia 11(4):286-291,
1992.
9. Brandom BW: Neuromuscular blocking drugs
in pediatric anesthesia. Seminars in Anesthesia 14(1):16-25,
1995.
Invited Published Papers:
1. Brandom BW: The effects of atracurium and
succinylcholine on the masseter. (Editorial) Can J Anaesth 37:7-11,
1990.
Letters:
1. Brandom BW, Cook DR. Dose response relationship
to mivacurium in humans. Anesthesiology 70:1036-7, 1989.
2. Brandom BW, Meretoja OA. Dose response calculations
revisited. (Comment on: Anesth Analg 1993;77:164-7.) Anesth Analg
78:608-9, 1994.
3. Brandom BW, Westman HR: The effects of
0.86 mg/kg of cisatracurium in an infant. Anesthesiology 85:688-9,
1996.
Proceedings:
1. Brandom BW, Brandom RB: A microcomputer
based model of anesthetic uptake and distribution. Modeling and
Simulation 11:295-300, 1980. Proceedings of the Eleventh Annual
Pittsburgh Conference.
2. Tung AS, Brandom BW: 4-aminopyridine reversal
of morphine analgesia in aminopyridines and similarly acting drugs:
Effects on nerves, muscles, and synapses. Proceedings of the IUPHAR
Satellite Symposium, 8th International Congress of Pharmacology,
Pans, France, July 27-29, 1981. Advances in the Biosciences
35:233, editors Lechat P, Thesleff S, Bowman WC. Pergamon Press,
1982.
3. Brandom BW, Cook, DR, Stiller RL: Pharmacokinetics
of atracurium in infants and children. Readings in Anesthesiology:
Neuromuscular Blocking Agents. Presented as a syllabus for
a symposium sponsored by Burroughs Wellcome Co. and the University
of Pittsburgh School of Medicine, Department of Anesthesiology,
1985.
Book Chapters:
1. Brandom BW, Cook DR: Muscle relaxants in
children. In: Muscle Relaxants, ed. Katz R, Grune &
Stratton, Inc., New York, NY, Chapter 14, pp. 215-232, 1985.
2. Brandom BW, Carroll JC, Rosenberg H: Malignant
hyperthermia. In: Smith's Anesthesia for Infants and Children,
Fifth Edition, eds. Motoyama EK and Davis PJ, C.V. Mosby Co.,
St. Louis, MO, Chapter 29, pp. 759-777, 1989.
3. Brandom BW: Is there a place for infusion
of muscle relaxants in clinical anesthesia? In: Problems in
Anesthesia: Neuromuscular Relaxants, ed. Rupp SM, J.B. Lippincott
Co., Philadelphia, PA, Vol. 3, No. 3, pp. 421-435, 1989.
4 Cook DR, Brandom BW: Pain control with general
and local anesthetics. In: Human Pharmacology, Molecular to
Clinical, eds. Wingard LB and Brody TM,
C.V. Mosby Co., St. Louis, MO, Chapter 30, 1991.
5. Brandom BW: Malignant hyperthermia and
neurolept syndromes. In: Pediatric Critical Care, eds.
Fuhrman BP and Zimmerman JJ, C.V. Mosby Co., St. Louis, MO, December,
1991.
6. Brandom BW: Masseter spasm. In: Common
Problems in Pediatric Anesthesia, 2nd Edition, ed.
Stehling L, C.V. Mosby Co., St. Louis, MO, Chapter 49, pp. 337-342,
1992.
7. Woelfel SK, Brandom BW: Anesthesia for
the pediatric ophthalmology patient. In: Duane's Clinical Ophthalmology,
eds. Tasman W and Jaeger EA,
J.B. Lippincott, Philadelphia, PA, 6(81):1-17, 1993.
8. Gronert BJ, Brandom BW: Neuromuscular blocking
drugs in infants and children. In: Pediatr Clin North Am,
ed. Wetzel RC, W.B. Saunders, Philadelphia, 41(1):73-91, 1994.
9. Brandom BW, Gronert GA: Malignant hyperthermia.
In: Smith's Anesthesia for Infants and Children Sixth
Edition, eds. Motoyama EK and Davis PJ, Mosby-Year Book, St.
Louis, Chapter 27, pp. 809-826, 1996.
Published Abstracts.
1. Motoyama EK, Brandom BW, Mestad PM, Walczak
SA: Esophageal pressure monitoring in infants. Anesthesiology
Vol 53, No. 3, September 1980.
2. Brandom BW, Lin M, Tung AS: 4-aminopyridine
reversal of ketamine anesthesia. The Pharmacologist Vol.
23, No. 3, 1981.
3. Tung AS, Brandom BW, Figallo EM: 4-aminopyridine
reversal of ketamine anesthesia and morphine analgesia. Anesthesiology
55:A240, September 1981.
4. Tung AS, Brandom BW: 4-aminopyridine reversal
of morphine analgesia. Abstracts of the Society for Neuroscience
11th Annual Meeting, p. 798. October 1981.
5. Cook DR, Brandom BW, Rudd D: Clinical pharmacology
of atracurium (BW33A) in pediatric patients. Anesthesiology
57:A415, 1982.
6. Brandom BW, Woelfel SK, Cook DR, Fehr B,
Rudd D: Relative potency of atracurium in children during halothane,
isoflurane or thiopental-fentanyl anesthesia. Anesthesiology
59:A442, 1983.
7. Brandom BW, Woelfel SK, Cook DR, Fehr B,
Rudd D: Clinical pharmacology of atracurium in infants. Anesthesiology
59:A440, 1983.
8. Cook DR, Brandom BW, Woelfel SK, Fehr B,
Rudd D: Atracurium infusion in children during fentanyl, halothane
and isoflurane anesthesia. Anesth Analg 63:201, 1984.
9. Cook DR, Brandom BW, Stiller RL, Woelfel
S, Lai A, Slater J: Pharmacokinetics of atracurium in normal and
liver failure patients. Anesthesiology 61:A433, 1984.
10. Brandom BW, Weber S, Cook DR, Powers D,
Woelfel SK, Marquez J, Weakly JN: Comparison of the effects of
BW B1090U and succinylcholine administered by bolus and infusion
in anesthetized patients. Anesthesiology 65:A288, 1986.
11. Cook DR, Stiller RL, Chakravorti S, Welch RM,
Brandom BW: In vitro metabolism of BW B1090U. Anesthesiology
67:A610, 1987.
12. Sarner JB, Brandom BW, Woelfel SK, Horn
M, Cook DR, Dong ML, Davis PJ, Foster VJ, McNulty BF: Neuromuscular
effects of BW A938U in anesthetized children. Anesthesiology
67:A365, 1987.
13. Powers D, Weber S, Brandom BW, Byers R,
Simpson K, Sarner J, Woelfel SK, Cook DR, McNulty BF, Foster VJ:
BW B1090U infusion requirements in adults during isoflurane or
narcotic anesthesia. Anesthesiology 67:A359, 1987.
14. Weber S, Brandom BW, Powers D, Sarner
JB, Woelfel SK, Cook DR, Foster VJ, Weakly JN: Relative potency
of BW B1909U during isoflurane or thiopental-fentanyl anesthesia.
Anesthesiology 67:A356, 1987.
15. Tullock WC, Diana P, Cook DR, Wilks DH, Brandom
BW, Beach CA: High dose vecuronium: Onset and duration. Anesth
Analg 67:S235, 1988.
16. Woelfel SK, Brandom BW, Sarner JB, Horn
M, Dong ML, Cook DR, Davis PJ, Foster VJ, McNulty BF: Potency
of mivacurium chloride (BW B1090U) during halothane-nitrous oxide
anesthesia in children. Anesth Analg 67:S261, 1988.
17. Brandom BW, Sarner JB, Dong ML, Horn M,
Woelfel SK, Cook DR, Borland LM, Davis PJ, Foster VJ, McNulty
BF: Mivacurium chloride (BW B1090U) infusion requirements in children
during halothane or narcotic anesthesia. Anesth Analg 67:S20,
1988.
18. Sarner JB, Brandom BW, Woelfel SK, Dong
ML, Horn M, Cook DR, Foster VJ, McNulty BF: Potency of mivacurium
chloride (BW B1090U) during narcotic-nitrous oxide anesthesia
in children. Anesthesiology 69:A522, 1988.
19. Woelfel SK, Brandom BW, Cook DR, Whitehead
B, Borland L: Relationship between the time to beginning of recovery
after the initial bolus of muscle relaxant and the infusion rate
requirements for mivacurium and succinylcholine. Anesthesiology
69:A521, 1988.
20. Brandom BW, Sarner JB, Dong ML, Woelfel
SK, Horn M, Cook DR, Foster VJ, McNulty BF: Plasma concentrations
of mivacurium chloride during infusion administration in children
anesthetized with halothane-nitrous oxide or narcotic-nitrous
oxide. Anesth Analg 68:S38, 1989.
21. Kusakawa I, Brandom BW, Motoyama E, Deneault
LG, Ochiai R, Lutz JW: Comparison of spontaneous inspiratory muscle
activities and train-of-four tibialis anterior response with low
dose atracurium in the cat. Anesthesiology 71:A1110, 1989.
22. Dong ML, Woelfel SK, Brandom BW, Sarner
JB, Cook DR: Vecuronium infusion requirements in children during
halothane-N2O, isoflurane-N2O,
and fentanyl-N2O anesthesia.
Anesthesiology 71:A1039, 1989.
23. Boston JR, Davis P, Brandom BW, Roeber
C: Similarity in time-related changes of somatosensory evoked
potentials and isoflurane. Anesthesiology 71:A398, 1989.
24. Sarner JB, Brandom BW, Dong ML, Pickle
D, Weinberger M, Cook DR: The cumulative dose-response relationship
of pipecuronium bromide (Arduan) in infants and children. Anesthesiology
71:A778, 1989.
25. Theroux MC, Brandom BW, Cook DR: Neuromuscular
monitoring of the flexor hallucis brevis compared with the adductor
pollicis in anesthetized children. Anesth Analg 70:S408,
1990.
26. Brandom BW, Georgiu E, Cook DR: Effects
of vecuronium on the flexor hallucis brevis compared with the
adductor pollicis in anesthetized children. Anesthesiology
73:A1112, 1990.
27. Brandom BW, Stiller RL, Cook DR, Scierka
AM: Differential rate of recovery of neuromuscular function in
the adductor pollicis and the flexor hallucis after vecuronium.
Anesthesiology 73:A1113, 1990.
28. Tullock WC, Wilks DH, Brandom BW, Diana
P, Cook DR: ORG9426 single dose-response, onset, and duration
with halothane anesthesia. Anesthesiology 73:A877, 1990.
29. Woelfel SK, Brandom BW, Sarner JB, Cook
DR, Cyran JA: Dose-response of ORG-9426 in children during nitrous
oxide-halothane anesthesia. Anesth Analg 72:S326, 1991.
30. Brandom BW, Woelfel SK, Sarner JB, Cook
DR: ORG 9426 infusion requirements in children during halothane
anesthesia. Anesthesiology 75:A1072, 1991.
31. Tullock WC, Wilks DH, Brandom BW, Cook
DR: ORG 9426: onset, intubation conditions and clinical duration.
Anesthesiology 75:A789, 1991.
32. Woelfel SK, Brandom BW, McGowan FX, Cook
DR: Dose-response relationships of mivacurium chloride (Mivacron)
in infants during nitrous oxide-halothane anesthesia. Anesthesiology
75:A775, 1991.
33. Woelfel SK, Brandom BW, McGowan FX, Cook
DR: Stability of Datex neuromuscular monitoring in anesthetized
infants. Anesth Analg 74:S352, 1992.
34. Powers D, Lefebvre D, Knos G, Cyran J, Brandom
BW: Intubation Conditions After Administration of ORG 9426
During Nitrous Oxide-Fentanyl-Midazolam Anesthesia. Anesth
Analg 74:S240, 1992.
35. Cook DR, Chakravorti S, Brandom BW, Stiller
RL: Effects of Neostigmine, Edrophonium and Succinylcholine on
the in vitro Metabolism of Mivacurium: Clinical Correlates. Anesthesiology
77:A948, 1992.
36. Woelfel SK, Brandom BW, McGowan FX, Cook
DR: Plasma Cholinesterase Activity and Response to Mivacurium
in Infants. Anesthesiology 77:A966, 1992.
37. Powers D, Lefebvre D, Knos G, Cyran J, Brandom
B: Intubation Conditions After Administration of ORG-9426
During Nitrous Oxide-Fentanyl-Midazolam Anesthesia. Anesth
Analg 74:S240, 1992.
38. Brandom BW, Meretoja
OA, Taivainen T, Wirtavuori K: A Small Dose of Pancuronium Preceding
Paralysis Induced by Mivacurium. Anesth Analg 76:S27, 1993.
39. Meretoja OA, Brandom BW, Wirtavuori K,
Taivainen T: Neuromuscular Effects of a Combination of Atracurium
and Vecuronium in Equipotent Ratio. Anesth Analg
76:S260, 1993.
40. Woelfel SK, Gronert BJ, Brandom BW, McGowan
FX, Cook DR: Effects of ORG-9426 in Infants During Halothane Anesthesia.
Anesth Analg 76:S467, 1993.
41 Brandom BW, Cook DR, Chakravorti S, Stiller
RL: Effects of Pancuronium and Vecuronium on the in vitro Metabolism
of Mivacurium, Succinylcholine and Propionylthiocholine. Anesthesiology
79:A949, 1993.
42. Theroux M, Brandom B, Zagnoev M, Kettrick
R: Dose Response of Succinylcholine in Anesthetized Children with
Cerebral Palsy. Anesthesiology 79:A1125, 1993.
43. Theroux MC, Zagnoev M, Brandom BW, Drago
LA: Comparison of Rapid Endotracheal Intubations Using Succinylcholine,
Mivacurium and Vecuronium to Combinations of Mivacurium and Vecuronium.
Anesth Analg 78:S436, 1994.
44. Simhi E, Brandom BW, Gronert BJ, Woelfel
SK: Timing of Intubation in Children After 300 mg/kg Mivacurium.
Anesthesiology 83:A902, 1995.
45. Taiwo OO, Woelfel SK, Brandom BW, Schoen
HE, Gronert BJ, Cook DR: Spontaneous vs Edrophonium Induced Recovery
From Paralysis with Mivacurium. Anesthesiology 83:A900,
1995.
46. Brandom BW, Woelfel SK, Gronert BJ, Cook
DR, Ference A, Dayal B: Effects of 51W89 (Cistracurium) in Children
during Halothane Nitrous Oxide Anesthesia. Anesthesiology
83:A921, 1995.
47. Brandom BW, Gronert BJ, Woelfel SK, Cook
DR: Lack of Synergy Between Mivacurium and Doxacurium or Pipecuronium.
Anesth Analg 82:S46, 1996.
48. Brandom BW, Gronert BJ, Yellon RF, Lloyd
ME, Shapiro AM, Rimmel FL: Doxacurium Infusion Given For More
Than Five Days In The Intensive Care Unit. Anesth Analg
82:S47, 1996.
49. Brandom BW, Meretoja OA, Gronert BJ, Woelfel
SK, Cook DR: Synergy Between Mivacurium and Pancuronium. Anesth
Analg 82:S48, 1996.
50. Simhi E, Brandom BW, Gronert BJ, Woelfel
SK: Intubation Scale For Children. Anesth Analg 82:S412,
1996.
51. Tarbell SE, Brandom BW, Davis PJ, Kosmach
B: Chronic Pain in Childhood: Add Munchausen by Proxy to the Differential
Diagnosis. 8th World congress on Pain, 1996.
52. Simhi E, Cook DR, Brandom BW, Lloyd ME,
Chakravorti S, Kuntz R. Pharmacokinetics of Mivacurium in anesthetized
Pediatric Patients undergoing Elective Surgery. Anesthesiology
85:A1061, 1996.
53. Brandom BW, Meretoja OA, Simhi E, Taivainen
T, Wolfe S, Woelfel SK, Gronert BJ, Cook DR: Effects of Mivacurium
0.3 mg/kg in pediatric surgical patients during nitrous oxide-halothane
compared with nitrous oxide-opioid anesthesia. Anesth Analg
84:S???1997.
54. Brandom BW, Lloyd ME, Woelfel SK, Simhi
E, Landsman IS. Comparison of the Datex Electromyograph and Paragraph
Monitors During Recovery from Pancuronium in Anesthestized Children.
Anesth Analg 84:S???1997.
55. Simhi E, Brandom BW, Lloyd ME, Woelfel
SK: Administration of atropine and onset of neuromuscular block
produced by atracurium in infants. Anesth Analg 84:S???1997.